AdvanSix (NYSE:ASIX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday.

According to Zacks, “AdvanSix Inc. is a producer and supplier of Nylon 6 materials. The company’s polymer resin sold under the Aegis(R) brand to produce engineered plastics, fibers, filaments and films which in turn used in end products such as automotive and electronic components, carpets, sports apparel, fishing nets and food as well as industrial packaging. AdvanSix also produces caprolactam, the main feedstock for producing nylon; Caprannylon film(R); Sulf-N (R) ammonium sulfate fertilizers and chemical intermediates, including phenol, acetone, and Nadone (R) cyclohexanone. AdvanSix Inc. is based in Morris Plains, United States. “

ASIX has been the topic of several other research reports. Cowen lifted their price target on shares of AdvanSix from $40.00 to $46.00 and gave the company an “outperform” rating in a research report on Friday, October 6th. BidaskClub raised shares of AdvanSix from a “buy” rating to a “strong-buy” rating in a research report on Saturday, September 23rd. Finally, ValuEngine lowered shares of AdvanSix from a “buy” rating to a “hold” rating in a research report on Friday, December 1st.

AdvanSix (ASIX) traded up $0.67 during mid-day trading on Tuesday, hitting $40.64. 334,416 shares of the stock traded hands, compared to its average volume of 267,438. The stock has a market cap of $1,225.72, a price-to-earnings ratio of 24.08 and a beta of 2.84. The company has a current ratio of 1.39, a quick ratio of 0.93 and a debt-to-equity ratio of 0.84. AdvanSix has a 1 year low of $19.74 and a 1 year high of $46.51.

In other news, Director Michael Marberry bought 539 shares of the business’s stock in a transaction on Wednesday, November 1st. The shares were bought at an average price of $46.41 per share, with a total value of $25,014.99. Following the completion of the transaction, the director now directly owns 16,420 shares in the company, valued at $762,052.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In the last three months, insiders acquired 1,741 shares of company stock worth $74,944. 2.70% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. UBS Asset Management Americas Inc. raised its position in AdvanSix by 5.8% in the second quarter. UBS Asset Management Americas Inc. now owns 9,132 shares of the company’s stock valued at $285,000 after purchasing an additional 498 shares during the period. Pacad Investment Ltd. increased its position in shares of AdvanSix by 16.7% during the second quarter. Pacad Investment Ltd. now owns 3,500 shares of the company’s stock worth $109,000 after acquiring an additional 500 shares during the period. Pinebridge Investments L.P. increased its position in shares of AdvanSix by 13.6% during the second quarter. Pinebridge Investments L.P. now owns 4,509 shares of the company’s stock worth $141,000 after acquiring an additional 539 shares during the period. Symphony Asset Management LLC increased its position in shares of AdvanSix by 4.1% during the second quarter. Symphony Asset Management LLC now owns 20,063 shares of the company’s stock worth $627,000 after acquiring an additional 784 shares during the period. Finally, AGF Investments Inc. increased its position in shares of AdvanSix by 1.7% during the second quarter. AGF Investments Inc. now owns 65,603 shares of the company’s stock worth $2,050,000 after acquiring an additional 1,111 shares during the period. 71.35% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: This piece was originally published by American Banking News and is owned by of American Banking News. If you are viewing this piece on another site, it was illegally copied and republished in violation of US & international copyright law. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/12/12/advansix-asix-cut-to-sell-at-zacks-investment-research.html.

AdvanSix Company Profile

AdvanSix Inc is an integrated manufacturer of Nylon 6. The Company also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process primarily, including caprolactam, ammonium sulfate fertilizers and other chemical intermediates. The Company operates primarily through its integrated manufacturing sites located in Frankford, Pennsylvania, Hopewell, Virginia, and Chesterfield, Virginia.

Get a free copy of the Zacks research report on AdvanSix (ASIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.